EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small cell lung cancer. Hastings K et…
この記事を読む
一臨床医の勉強のための備忘録です。間違いなどあればご指摘を頂ければ幸いです。
この記事を読む
EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small cell lung cancer. Hastings K et…
この記事を読む
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a rand…
この記事を読む
Outcomes to first-line pembrolizumab in patients with non-small cell lung cancer and very high PD-L1 expression. Aguilar…
この記事を読む
Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled anal…
この記事を読む
Comparative study of EGFR mutations detected in malignant pleural effusion, plasma and tumor tissue in patients with ade…
この記事を読む
Palliative thoracic radiotherapy near the end of life in lung cancer: A population-based analysis. Fraser I et al. Lung …
この記事を読む
Comprehensive Clinical and Genetic Characterization of Hyperprogression Based on Volumetry in Advanced Non-Small Cell Lu…
この記事を読む
Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immun…
この記事を読む
Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer. Noronha V et al. J …
この記事を読む
Early serum tumor marker dynamics predict progression-free and overall survival in single PD-1/PD-L1 inhibitor treated a…